Literature DB >> 22426339

IFN-γ-driven IDO production from macrophages protects IL-4Rα-deficient mice against lethality during Schistosoma mansoni infection.

Reena Rani1, Michael B Jordan, Senad Divanovic, De'Broski R Herbert.   

Abstract

The balance between alternatively activated macrophages (AAMs)/M2 cells and classically activated macrophages (M1 cells) is largely dependent on the effects of IL-4 and interferon (IFN)-γ, respectively. Although AAM/M2 cells can suppress inflammation and repair damaged tissue, M1 cells produce an array of pro-inflammatory molecules. Macrophage effector functions are critical for host protection against many infectious diseases, but it remains unknown whether lethal immunopathological characteristics, caused by Schistosoma mansoni infection in IL-4 receptor α-deficient mice (IL-4Rα(-/-)), results from the absence of M2 cells or increased numbers of M1 cells. In this study, we generated mice that completely lack IL-4Rα signaling in the context of a macrophage-specific loss of IFN-γ responsiveness (MIIG × IL-4Rα(-/-)). Contrary to what we expected, acute schistosomiasis resulted in greater liver injury and mortality in MIIG × IL-4Rα(-/-) mice compared with IL-4Rα(-/-) mice. Greater tissue injury in MIIG × IL-4Rα(-/-) mice was likely because of a lack of indoleamine 2,3 dioxygenase (IDO), a critical regulator of immunosuppression. Indeed, MIIG × IL-4Rα(-/-) failed to up-regulate IDO expression, and IL-4Rα(-/-) mice treated with an IDO antagonist underwent greater liver damage and mortality compared with mock-treated IL-4Rα(-/-) mice. Thus, we propose that, in the absence of AAM/M2 cells, IFN-γ-induced M1 cells suppress tissue-damaging inflammation during acute schistosomiasis through an IDO-dependent mechanism.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22426339      PMCID: PMC3349826          DOI: 10.1016/j.ajpath.2012.01.013

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis.

Authors:  De'Broski R Herbert; Tatyana Orekov; Amanda Roloson; Monica Ilies; Charles Perkins; William O'Brien; Stephen Cederbaum; David W Christianson; Nives Zimmermann; Marc E Rothenberg; Fred D Finkelman
Journal:  J Immunol       Date:  2010-05-05       Impact factor: 5.422

Review 2.  Human schistosomiasis.

Authors:  Bruno Gryseels; Katja Polman; Jan Clerinx; Luc Kestens
Journal:  Lancet       Date:  2006-09-23       Impact factor: 79.321

3.  Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent.

Authors:  P G Fallon; E J Richardson; G J McKenzie; A N McKenzie
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

4.  Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.

Authors:  De-Yan Hou; Alexander J Muller; Madhav D Sharma; James DuHadaway; Tinku Banerjee; Maribeth Johnson; Andrew L Mellor; George C Prendergast; David H Munn
Journal:  Cancer Res       Date:  2007-01-15       Impact factor: 12.701

5.  Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivo.

Authors:  Jennifer E Lykens; Catherine E Terrell; Erin E Zoller; Senad Divanovic; Aurelien Trompette; Christopher L Karp; Julio Aliberti; Matthew J Flick; Michael B Jordan
Journal:  J Immunol       Date:  2009-12-14       Impact factor: 5.422

6.  IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis.

Authors:  De'Broski R Herbert; Tatyana Orekov; Charles Perkins; Fred D Finkelman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  IFN-gamma-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo.

Authors:  Young H Kim; Beom K Choi; Woo J Kang; Kwang H Kim; Sang W Kang; Andrew L Mellor; David H Munn; Byoung S Kwon
Journal:  J Leukoc Biol       Date:  2009-02-13       Impact factor: 4.962

Review 8.  Alternatively activated macrophages in helminth infections.

Authors:  Timothy Kreider; Robert M Anthony; Joseph F Urban; William C Gause
Journal:  Curr Opin Immunol       Date:  2007-08-16       Impact factor: 7.486

Review 9.  Exploring the full spectrum of macrophage activation.

Authors:  David M Mosser; Justin P Edwards
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

10.  Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung.

Authors:  Meera G Nair; Yurong Du; Jacqueline G Perrigoue; Colby Zaph; Justin J Taylor; Michael Goldschmidt; Gary P Swain; George D Yancopoulos; David M Valenzuela; Andrew Murphy; Margaret Karow; Sean Stevens; Edward J Pearce; David Artis
Journal:  J Exp Med       Date:  2009-04-06       Impact factor: 14.307

View more
  11 in total

1.  Hematopoietic MyD88 and IL-18 are essential for IFN-γ-dependent restriction of type A Francisella tularensis infection.

Authors:  Jerod A Skyberg; Carolyn A Lacey
Journal:  J Leukoc Biol       Date:  2017-09-26       Impact factor: 4.962

Review 2.  Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.

Authors:  Tracy L McGaha; Lei Huang; Henrique Lemos; Richard Metz; Mario Mautino; George C Prendergast; Andrew L Mellor
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

Review 3.  Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.

Authors:  Aitziber Buqué; Norma Bloy; Fernando Aranda; Isabelle Cremer; Alexander Eggermont; Wolf Hervé Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2016-03-10       Impact factor: 8.110

Review 4.  Trial watch: IDO inhibitors in cancer therapy.

Authors:  Erika Vacchelli; Fernando Aranda; Alexander Eggermont; Catherine Sautès-Fridman; Eric Tartour; Eugene P Kennedy; Michael Platten; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-15       Impact factor: 8.110

5.  Brugia malayi Microfilariae Induce Autophagy through an Interferon-γ Dependent Mechanism on Human Monocytes.

Authors:  Prakash Babu Narasimhan; Sameha Tariq; Leor Akabas; David W Dorward; Thomas B Nutman; Roshanak Semnani
Journal:  Am J Trop Med Hyg       Date:  2022-02-28       Impact factor: 2.345

6.  Cx3cr1 deficiency in mice attenuates hepatic granuloma formation during acute schistosomiasis by enhancing the M2-type polarization of macrophages.

Authors:  Lin Ran; Qilin Yu; Shu Zhang; Fei Xiong; Jia Cheng; Ping Yang; Jun-Fa Xu; Hao Nie; Qin Zhong; Xueli Yang; Fei Yang; Quan Gong; Michal Kuczma; Piotr Kraj; Weikuan Gu; Bo-Xu Ren; Cong-Yi Wang
Journal:  Dis Model Mech       Date:  2015-04-21       Impact factor: 5.758

7.  Aryl hydrocarbon receptor signaling regulates NF-κB RelB activation during dendritic-cell differentiation.

Authors:  Christoph F A Vogel; Dalei Wu; Samuel R Goth; Jaeeun Baek; Anna Lollies; Rowena Domhardt; Annemarie Grindel; Isaac N Pessah
Journal:  Immunol Cell Biol       Date:  2013-09-03       Impact factor: 5.126

Review 8.  Role of IL-4Rα during acute schistosomiasis in mice.

Authors:  H Ndlovu; F Brombacher
Journal:  Parasite Immunol       Date:  2014-09       Impact factor: 2.280

Review 9.  Role of Macrophages in the Repair Process during the Tissue Migrating and Resident Helminth Infections.

Authors:  Berenice Faz-López; Jorge Morales-Montor; Luis I Terrazas
Journal:  Biomed Res Int       Date:  2016-08-25       Impact factor: 3.411

10.  Inflammatory Dendritic Cells, Regulated by IL-4 Receptor Alpha Signaling, Control Replication, and Dissemination of Leishmania major in Mice.

Authors:  Ramona Hurdayal; Natalie Eva Nieuwenhuizen; Rethabile Khutlang; Frank Brombacher
Journal:  Front Cell Infect Microbiol       Date:  2020-01-24       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.